tracken
Danaher Aktie News
Neutral
GlobeNewsWire
●
ein Tag alt
NEW YORK, Oct. 26, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corporation (NYSE: DHR).
Neutral
Business Wire
●
3 Tage alt
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Danaher Corporation (NYSE: DHR) breached their fiduciary duties to shareholders. If you currently own Danaher stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved fin...
Neutral
GlobeNewsWire
●
4 Tage alt
NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corporation (NYSE: DHR).
Positiv
Seeking Alpha
●
5 Tage alt
Danaher Corporation is regaining growth momentum, with strong Q3 results, positive 2026 guidance, and robust performance in its Biotechnology segment. DHR's management maintains conservative full-year guidance, opting to reinvest Q3 outperformance and accelerate share buybacks, signaling confidence in future earnings expansion. The company is well-positioned in China despite VBP headwinds, with...
Positiv
Seeking Alpha
●
5 Tage alt
Danaher Corporation reported solid Q3/25 results with 4.4% revenue growth and improved margins, yet valuation concerns persist. Despite management's optimism for high single-digit long-term growth, Danaher faces risks from China exposure, tariffs, and global market pressures. Danaher trades at high valuation multiples, and even optimistic DCF assumptions only justify a fair value, not an underv...
Neutral
PRNewsWire
●
6 Tage alt
NEW YORK , Oct. 21, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corporation (NYSE: DHR). If you currently own shares of Danaher stock, please visit the firm's website at https://rosenlegal.com/submit-form/?case_id=17717 for more information.
Positiv
The Motley Fool
●
6 Tage alt
Danaher's biotechnology growth prospects look assured. Guidance for 2026 is merely within the range of current market expectations.
Positiv
Investors Business Daily
●
6 Tage alt
Shares of Danaher surged Tuesday after the medical research company beat third-quarter forecasts on the back of its bioprocessing division.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
